GEHC
USDGE HealthCare Technologies Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$74.380
Kõrge
$75.490
Madal
$73.900
Maht
0.47M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
33.9B
Tööstusharu
Health Information Services
Riik
United States
Kauplemisstatistika
Keskmine maht
3.32M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Morgan Stanley Maintains Equal-Weight on GE HealthCare Techs, Raises Price Target to $80
Morgan Stanley analyst Patrick Wood maintains GE HealthCare Techs with a Equal-Weight and raises the price target from $74 to $80.
Evercore ISI Group Maintains Outperform on GE HealthCare Techs, Raises Price Target to $92
Evercore ISI Group analyst Vijay Kumar maintains GE HealthCare Techs with a Outperform and raises the price target from $88 to $92.
Wells Fargo Maintains Overweight on GE HealthCare Techs, Lowers Price Target to $87
Wells Fargo analyst Larry Biegelsen maintains GE HealthCare Techs with a Overweight and lowers the price target from $89 to $87.
GE HealthCare boosts 2025 profit view after strong US demand helps third quarter
GE HealthCare Technologies raised its annual adjusted profit forecast and beat estimates for third-quarter results on Wednesday, powered by strong demand for its medical devices in the United States and the Europe, Middle East, and Africa region.
GE HealthCare reports third quarter 2025 financial results
Revenue growth was 6% and Organic revenue growth* was 4% year-over year, driven by Europe, the Middle East and Africa (EMEA) and the U.S. Organic orders growth was 6% with growth across all segments Net
GE HealthCare launches CareIntellect for Perinatal, a cloud-first application to optimize care delivery and help send families home healthy
Informed by clinicians and built on clinical insights, the solution provides care teams with real-time1 insights designed to streamline perinatal workflows and support timely clinical decision-making. Developed in
BTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $89
BTIG analyst Ryan Zimmerman maintains GE HealthCare Techs with a Buy and raises the price target from $87 to $89.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.